Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study.
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
Phenotypic Plasticity and Cancer: A System Biology Perspective.
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies.
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis.
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis. Biochim Biophys Acta Rev Cancer. 2020 01; 1873(1):188337.
View in:
PubMed
subject areas
ATP-Binding Cassette Transporters
Cell Membrane
Clathrin
Endocytosis
GTPase-Activating Proteins
Humans
Ligands
Membrane Proteins
Protein Binding
Protein Transport
Signal Transduction
authors with profiles
Ravi Salgia